American Johnson local time on August 19，The company has completed the acquisition of Aragon Pharmaceuticals Inc.，The latter specializes in the discovery and research and development of the treatment of hormone -affecting cancer drugs in the treatment of hormones。
    As early as June this year Johnson & Johnson plans to acquire Aragon Pharmaceuticals at a price of $ 1 billion。It is reported，For Aragon's male hormone receptor antagonist project, My stake betting appcompounds stake sports betting appof compounds will be delivered to Jenssen Research & Development) Responsible，This project includes ARAGON's leadingrogen hormone receptor signal inhibitor Arn-509。
    Yang Sen's in charge of the field of tumor therapy in the field of tumor treatment/PhD in science at Peterlebowitz said: & ldquo; the second generation of Aragon，It may be that the best compounds of the same type will strengthen our research in the field of prostate cancer。It gives us the opportunity to further expand on the basis of the existing drug acetic acid amibil dragon leading position，If the relevant items are approved，We hope that ARN-509 can make us meet the widespread My stake betting appneeds Stake Sports Bettingof patients with prostate cancer。& rdquo;